Pasquale Fonzetti is a Neurology physician affiliated with WestCon Medical. OpenAlex indexes 16 publications with 1,144 citations (h-index 12); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3030 Westchester Ave
Purchase, NY 105772574
Telephone
914-607-5830Registry record last updated 3 Dec 2019.
Clinical trials
- Benfotiamine in Alzheimer's Disease: A Pilot Study
Sponsor: Burke Medical Research Institute
- Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke
Sponsor: Burke Rehabilitation Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year20251 payment
- Biogen, Inc.Program year202112 payments$16,334openpaymentsdata.cms.gov ↗
- Alkermes, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
95.1%Cholinesterase Inhibitor20.7%Donepezil Hcl84%Galantamine Hbr10%Rivastigmine5%Part D<11 patientsN-methyl-D-aspartate Receptor Antagonist16.7%Memantine Hcl98%Memantine Hcl Er2%Part D<11 patients+ 21 more classes in this area
Respiratory
1.7%Histamine-1 Receptor Antagonist1.7%Diphenhydramine hcl100%Part B, office-administered≥13 patientsCardiovascular
1.6%Beta blocker0.7%Propranolol Hcl52%Nadolol48%Part D<11 patientsStatin0.5%Atorvastatin Calcium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2017–2018 per NIH RePORTER. The latest:
- Benfotiamine in Alzheimer's Disease: A pilot study
Winifred Masterson Burke Med Res Inst
FY2018$328,785R01AG043679 - Benfotiamine in Alzheimer's Disease: A pilot study
Winifred Masterson Burke Med Res Inst
FY2017$328,785R01AG043679
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Expanded Exploration of the Auditory Naming Test in Patients with Dementia
Journal of Alzheimer s Disease
2021 - Benfotiamine and Cognitive Decline in Alzheimer’s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial
Journal of Alzheimer s Disease
2020 - Paired Associative Stimulation as a Tool to Assess Plasticity Enhancers in Chronic Stroke
Frontiers in Neuroscience
2019 - [P2–019]: GLUCOSE METABOLISM AS A THERAPEUTIC TARGET IN ALZHEIMER's DISEASE
Alzheimer s & Dementia
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”